Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Oktober 2023 13:00 ET | Quelle: DelveInsight Business Research LLP

Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight

New York, USA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019–2032), Analysis by DelveInsight ...
21. September 2022 13:00 ET | Quelle: DelveInsight Business Research LLP

40+ Key Companies Actively Working in the Marginal Zone Lymphoma Pipeline Segment | DelveInsight

New York, USA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- 40+ Key Companies Actively Working in the Marginal Zone Lymphoma Pipeline Segment | DelveInsight Marginal Zone Lymphoma Pipeline constitutes 40+...
19. Februar 2019 16:30 ET | Quelle: BeiGene, LTD.

BeiGene Initiates Global Phase 2 Trial of Zanubrutinib in Patients with Relapsed or Refractory Marginal Zone Lymphoma

CAMBRIDGE, Mass. and BEIJING, China, Feb. 19, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...